New data on T cells' protective role suggests need for new approach to dengue vaccine design

16-04-2013

As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The ...

more

20-02-2013

The new coronavirus that has emerged in the Middle East is well-adapted to infecting humans but could potentially be treated with immunotherapy, according to a study to be published online in the journal of the American Society for Microbiology. The study indicates that the virus HCoV-EMC can ...

more

13-02-2013

The need for quality care, especially for a rapidly ageing population, is a strong driving factor for the tissue sealants and haemostats market in Western Europe. Technologically advanced products that enhance surgical efficiency and patient safety will also boost market prospects. New ...

more

20-02-2012

A team of international researchers is working to tackle the global problem of plant viral diseases that are spread by insects, thanks to close to $1 million from the National Science Foundation (NSF) and the Bill & Melinda Gates Foundation.The team, headed by Stewart Gray, a U.S. Department ...

more

Mechanism explains how virus survives in the liver and how a new antiviral works

04-01-2012

Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them very difficult to target with medical treatment.Scientists at the ...

more

25-08-2010

PBL InterferonSource announced that its founder and chief scientific officer (CSO), Sidney Pestka, M.D., will receive the 'Distinguished Service Award' from the International Society for Interferon and Cytokine Research (ISICR) at the ISICR's annual meeting on October 3-7, 2010, in ...

more

23-08-2010

New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposure — suggesting the approach holds promise for treating ...

more

09-04-2010

The human body has developed various mechanisms, through which it can protect itself against newly-developing cancer cells. For instance, killer-cells recognize and destroy altered cells in our organs every day. Once tumours have developed, they may be inhibited in growth by messenger ...

more

07-04-2010

AmVac AG has been granted a European patent (EP 1851 239 B1) for its Sendai platform technology for its subsidiary company AmVac Research GmbH. Thus, the novel technology for producing vaccines that has been developed at the research site in Martinsried, Germany, is completely covered by the ...

more

22-02-2010

After testing dozens of samples from marine mammals, University of Florida aquatic animal health experts say they have found the ideal model for the study of cervical cancer in people. “We discovered that dolphins get multiple infections of papillomaviruses, which are known to be linked ...

more